Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 32 (November 10), 2007: pp. 5063-5069
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.11.0197

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganz, P. A.
Right arrow Articles by Gotay, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganz, P. A.
Right arrow Articles by Gotay, C. C.

REVIEW ARTICLE

Use of Patient-Reported Outcomes in Phase III Cancer Treatment Trials: Lessons Learned and Future Directions

Patricia A. Ganz, Carolyn C. Gotay

From the University of California, Los Angeles Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, CA; and Cancer Research Center of Hawaii, Honolulu, HI

Address reprint requests to Patricia A. Ganz, MD, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Dr South, Rm A2-125 CHS, Los Angeles, CA 90095-6900; e-mail: pganz{at}ucla.edu

Purpose: This article examines the challenges, opportunities, and successes that have occurred in the incorporation of patient-reported outcomes (PROs) in phase III cancer clinical trials.

Methods: An informal survey of the leadership of US cooperative group PRO investigators identified diverse trials in which PROs had been measured. Exemplary trials were selected for lessons learned and for examination of successful strategies.

Results: We review four challenging trials in depth, illustrating some of the difficulties in integrating PROs within treatment trials, including issues related to missing data, lack of procedures for monitoring patients and ensuring collection of PRO data, and missed opportunities in publication of treatment and PRO outcomes together. Four examples of successful trials are highlighted.

Conclusion: As a result of this review, the authors make specific recommendations related to the use of PROs in phase III trials, focusing on issues related to design, choice of PRO instrument and frequency of administration, analysis, and publication strategies.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. B. Montgomery, E. A. Mostaghel, R. Vessella, D. L. Hess, T. F. Kalhorn, C. S. Higano, L. D. True, and P. S. Nelson
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
Cancer Res., June 1, 2008; 68(11): 4447 - 4454.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. M. Moinpour, A. M. Denicoff, D. W. Bruner, A. B. Kornblith, S. R. Land, A. O'Mara, and E. Trimble
Funding Patient-Reported Outcomes in Cancer Clinical Trials
J. Clin. Oncol., November 10, 2007; 25(32): 5100 - 5105.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Lipscomb, B. B. Reeve, S. B. Clauser, J. S. Abrams, D. Watkins Bruner, L. B. Burke, A. M. Denicoff, P. A. Ganz, K. Gondek, L. M. Minasian, et al.
Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward
J. Clin. Oncol., November 10, 2007; 25(32): 5133 - 5140.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online